Safeguard Investment Advisory Group »

Teva Pharmaceutical Industries shares owned by Safeguard Investment Advisory Group

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Safeguard Investment Advisory Group from 13F filings

Historical chart of Safeguard Investment Advisory Group investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Safeguard Investment Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Safeguard Investment Advisory Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $290k 14k 20.20
2025-06-30 $243k 15k 16.76
2025-03-31 $213k 14k 15.37
2024-12-31 $210k 9.5k 22.04
2020-12-31 $42k 4.4k 9.57

More positions owned by Safeguard Investment Advisory Group

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us High Profitab (DUHP)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr U.s. Med Dvc Etf (IHI)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Vanguard World Health Car Etf (VHT)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Microsoft Corporation (MSFT)
Vanguard Specialized Funds Div App Etf (VIG)
Broadcom (AVGO)

View all positions for Safeguard Investment Advisory Group

Top funds holding Teva Pharmaceutical Industries

BlackRock
Phoenix Holdings
Menora Mivtachim Holdings
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Clal Insurance Enterprises Holdings
Exor Investments
Rubric Capital Management
FMR
PointState Capital
State Street Corporation
Glenview Captal Management
Duquesne Family Office
Jane Street
Susquehanna International

View all funds holding Teva Pharmaceutical Industries